TAFA-93

N/A

Report date: 2026/03/06 20:02:51
NME

Base Information

Drug NameTAFA-93
Drug Alias NameTAFA-93
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine/threonine-protein kinase mTOR inhibitors
TargetsSerine/threonine-protein kinase mTOR
Therapy Area/IndicationsRejection in heart transplantation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAurinia
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAtriumAurinia
Active IndicationsN/A
Inactive IndicationsRejection in heart transplantation

Other Information

ATC CodeN/A
Related LinksDrugBank